Semalix 3 Tablet is used for:

• Type 2 diabetes mellitus: It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

• Treatment initiation: The 3 mg strength is generally used during the initial stage of Semaglutide treatment before increasing to a higher strength when prescribed.

Semalix 3 Tablet contains Semaglutide, which mimics the action of a natural hormone called GLP-1 (glucagon-like peptide-1). It helps the pancreas release insulin when blood glucose levels are high and reduces the release of glucagon, a hormone that raises blood glucose.

Semaglutide also slows stomach emptying and can increase feelings of fullness. These effects help improve blood sugar control and may also reduce appetite.

Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, supplements and herbal products you take.

• Insulin and sulfonylureas: Using Semalix with insulin or sulfonylureas can increase the risk of low blood sugar. Your doctor may adjust the dose of these medicines.

• Other oral medicines: Semaglutide delays stomach emptying and may affect the absorption of some medicines taken by mouth. This is particularly important for medicines that require close monitoring.

• Other Semaglutide-containing medicines: Do not use Semalix with another Semaglutide-containing medicine unless specifically prescribed by your doctor.

• Other GLP-1 receptor agonists: Do not combine Semalix with another GLP-1 receptor agonist unless advised by your doctor.

• Store Semalix 3 Tablet below 30°C.

• Keep the tablets in their original packaging and protect them from moisture.

• Keep Semalix 3 Tablet out of the sight and reach of children.

Take Semalix 3 Tablet exactly as prescribed by your doctor.

• Take it once daily, first thing in the morning on an empty stomach.

• Swallow the tablet whole with a small amount of plain water. Do not split, crush or chew it.

• Take Semalix at least 30 minutes before eating, drinking or taking any other oral medicine.

• The 3 mg strength is generally taken for the initial 30 days before increasing to 7 mg, if prescribed.

• Do not change the dose or stop treatment without speaking with your doctor.

• If you miss a dose, skip it and take your next dose on the following day at the usual time. Do not take two doses together.

Common side effects:

• Nausea

• Abdominal pain

• Diarrhoea

• Decreased appetite

• Vomiting

• Constipation

These effects are more likely during dose escalation and may improve as your body adjusts to treatment.

Serious side effects:

• Pancreatitis: Severe or persistent abdominal pain, sometimes spreading to the back, with or without vomiting.

• Severe gastrointestinal reactions: Persistent or severe vomiting, diarrhoea or stomach-related symptoms.

• Low blood sugar: Particularly when Semalix is used with insulin or sulfonylureas.

• Acute kidney injury: Severe dehydration caused by prolonged vomiting or diarrhoea can affect kidney function.

• Diabetic retinopathy complications: Report new or worsening vision changes, particularly if you already have diabetic retinopathy.

• Gallbladder problems: Severe abdominal pain, fever, jaundice or other symptoms that may indicate gallstones or gallbladder inflammation.

• Serious allergic reactions: Swelling of the face, lips, tongue or throat, difficulty breathing or severe skin reactions.

Seek prompt medical attention if you develop any of these symptoms.

• Take Semalix 3 Tablet exactly as prescribed and do not increase the dose yourself.

• Take the tablet on an empty stomach with only a small amount of plain water.

• Wait at least 30 minutes before eating, drinking or taking other oral medicines.

• Keep regular blood sugar monitoring and follow-up appointments with your doctor.

• Tell your doctor if you take insulin or a sulfonylurea because the risk of hypoglycaemia may increase.

• Tell your doctor if you have diabetic retinopathy, a history of pancreatitis or severe gastrointestinal problems.

• Do not use Semalix with another Semaglutide-containing medicine or another GLP-1 receptor agonist unless specifically prescribed.

• Tell your doctor before any procedure involving general anaesthesia or deep sedation.

• Semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2).